Older adults taking GLP-1 receptor agonists, primarily semaglutide (Rybelsus, Ozempic, Wegovy), had a small uptick in their ...

The researchers discovered that after just six months of use, patients had double the risk of developing neovascular ...

Ozempic and Wegovy have been hailed as wonder drugs when it comes to weight loss. But as the drug has become more widely used ...

Interim results from the Phase II COURAGE trial show that combining semaglutide with anti-GDF8 antibody trevogrumab preserves ...

A combination treatment of semaglutide, trevogrumad and garetosmab causes fat loss and muscle growth in primate trials. Full ...

By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...

A popular weight-loss drug may be changing how doctors treat obesity—but scientists are just starting to uncover exactly how ...

FDA seizes hundreds of fake Ozempic units from US supply after Novo Nordisk alerts regulators to counterfeit semaglutide ...

Ozempic, which was introduced into the UK in January 2019, having previously been approved in the US in 2017, is an ...

Scientists found brain cells behind semaglutide’s weight-loss power—and they don’t cause the nasty side effects.

A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...